What can be done for hair loss in women on testosterone replacement therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hair Loss with Testosterone Replacement Therapy in Women

Testosterone replacement therapy at physiologic doses does not cause hair loss in women and may actually improve scalp hair growth in androgen-deficient women. 1

Evidence Against TRT Causing Hair Loss

The New England Journal of Medicine explicitly states there is no data indicating acceleration of male-pattern baldness in patients receiving testosterone replacement therapy, though this has not been rigorously studied in controlled trials. 2, 1 This guideline evidence directly contradicts the common assumption that testosterone worsens hair loss.

In fact, testosterone therapy may improve hair growth in women with androgen deficiency:

  • In a study of 285 women treated with subcutaneous testosterone implants for androgen deficiency, 27% reported hair thinning prior to treatment. 3
  • Of those with pre-treatment hair loss, 63% reported hair regrowth on testosterone therapy. 3
  • Critically, no patient in this cohort reported scalp hair loss as a result of testosterone treatment. 3
  • Women who reported baseline hair loss had significantly lower serum testosterone levels than those without hair loss (P=0.0001). 3

Mechanism and Clinical Context

The beneficial effect appears related to testosterone's anabolic effect on hair follicles in androgen-deficient women. 3 This is fundamentally different from the androgenetic alopecia seen in:

  • Female-to-male transgender patients receiving supraphysiologic testosterone doses (targeting 300-1,000 ng/dL) who have no prior androgen exposure. 1
  • Women with female pattern hair loss who have increased testosterone production rates (9.4±5.0 μg/h vs normal 4.3±1.9 μg/h) but normal or low DHT production. 4

Management Approach

For women on TRT experiencing hair loss, the priority is ruling out other causes rather than stopping testosterone:

  • Check thyroid function (TSH, free T4), iron stores (ferritin), vitamin D, and zinc levels. 2
  • Examine for female-pattern hair loss, alopecia areata, or inflammatory (scarring) alopecia. 2
  • Verify testosterone dosing targets mid-normal range, not supraphysiologic levels. 1

If hair loss persists despite normal labs and appropriate testosterone dosing:

  • Consider oral antiandrogens (spironolactone 200 mg daily or cyproterone acetate 50-100 mg), which showed 88% of women had stabilization or improvement of hair loss. 5
  • Note that 5α-reductase inhibitors are unlikely to help, as women with female pattern hair loss have normal or low DHT production despite elevated testosterone. 4

Key Clinical Pitfall

Do not automatically attribute hair loss to testosterone therapy. The evidence shows testosterone at replacement doses does not cause hair loss and may improve it in androgen-deficient women. 1, 3 Stopping or reducing testosterone based on this misconception may worsen both the underlying androgen deficiency symptoms and potentially the hair loss itself. 3

Monitoring Considerations

Standard TRT monitoring protocols do not include hair loss assessment as a routine parameter, focusing instead on PSA, hematocrit/hemoglobin, and clinical response to therapy. 1 Hair changes should prompt evaluation for alternative causes rather than automatic dose reduction. 2

References

Guideline

Testosterone Replacement Therapy and Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of female pattern hair loss with oral antiandrogens.

The British journal of dermatology, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.